Ajax-Loading

Sanofi SA - Operating Income

Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.

The item "Operating-Income" stands at 8.57 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.

Sanofi SA's third quarter result of 3.62 Billion EUR for the item "Operating Income" represents an increase of 145.79 percent compared to it's second quarter result.

Also, Sanofi SA's third quarter result of 3.62 Billion EUR for the item "Operating Income" represents a decrease of -0.33 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 8.57 Billion EUR for the item "Operating Income" represents a decrease of -0.14 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.83 percent compared to the value the year prior.
The 1 year change in percent is 7.83.
The 3 year change in percent is 6.77.
The 5 year change in percent is -31.54.
The 10 year change in percent is 26.00.

The Serie's long term average value is 7.47 Billion Euros. It's latest available value, on 09/30/2025, is 14.63 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2019, to it's latest available value, on 09/30/2025, is +181.44%.
The Serie's change in percent from it's maximum value, on 03/31/2021, to it's latest available value, on 09/30/2025, is -39.35%.

Operating Income for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Operating Income905,699,262,464.00
LogoJohnson & Johnson - Operating Income486,508,953,600.00
LogoAbbVie Inc - Operating Income399,570,305,024.00
LogoRoche Holding AG - Operating Income317,433,206,677.55
LogoAstraZeneca PLC - Operating Income280,205,508,085.11